Search Results

Athersys, Inc. announces that Dr. Samuel Tingle, a surgeon and PhD candidate at Newcastle University in Newcastle upon Tyne, England, has received grant funding from the UK Research and Innovation’s Medical Research Council to explore the potential use of Athersys’ MultiStem cellular therapy during machine perfusion prior to kidney transplantation.

GBS Inc., a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, announced that the Company and the University of Newcastle in Australia have selected a site for its proprietary biosensor technology.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

Albany NY, United States: Newcastle disease is a viral disease caused by avian paramyxovirus type 1.